Bridges Middle School Welcomes Mattel’s First Autistic Barbie Doll as Milestone for Representation

Bridges Middle School Welcomes Mattel's First Autistic Barbie Doll as Milestone for Representation Oregon neurodivergent education leader affirms significance of inclusive toy design GlobeNewswire January 20, 2026 El Segundo, CA, Jan. 20, 2026 (GLOBE NEWSWIRE) — Bridges Middle School has affirmed the educational significance of Mattel Inc.'s newly launched autistic Barbie doll, calling the release […]

AQUESTIVE ALERT: Bragar Eagel & Squire, P.C. is Investigating Aquestive Therapeutics, Inc. on Behalf of Aquestive Stockholders and Encourages Investors to Contact the Firm

AQUESTIVE ALERT: Bragar Eagel & Squire, P.C. is Investigating Aquestive Therapeutics, Inc. on Behalf of Aquestive Stockholders and Encourages Investors to Contact the Firm GlobeNewswire January 20, 2026 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Aquestive (AQST) To Contact Him Directly To Discuss Their Options If you

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA – ADCT

(NYSE:ADCT), NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA (“ADC Therapeutics” or the “Company”) (NYSE: ADCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether ADC Therapeutics and certain of its officers and/or

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. – LENZ

(NASDAQ:LENZ), NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of LENZ Therapeutics, Inc. (“LENZ” or the “Company”) (NASDAQ: LENZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether LENZ and certain of its officers and/or directors have

Infinite Eagle Acquisition Corp., Led by Eagle Equity Partners’ Harry Sloan, Jeff Sagansky and Eli Baker, Announces Completion of $300 million IPO

(NasdaqGM:IEAG),(NasdaqGM:IEAGU),(NasdaqGM:IEAGR), Infinite Eagle Features a Warrantless Structure Each Unit Includes One Class A Ordinary Share and One Eagle Share Right to Receive 1/25th of a Class A Ordinary Share NEW YORK, NY, Jan. 20, 2026 (GLOBE NEWSWIRE) — Infinite Eagle Acquisition Corp. (the “Company”), the tenth public acquisition vehicle sponsored by Eagle Equity Partners, which

Infinite Eagle Acquisition Corp., Led by Eagle Equity Partners’ Harry Sloan, Jeff Sagansky and Eli Baker, Announces Completion of $300 million IPO

Infinite Eagle Acquisition Corp., Led by Eagle Equity Partners' Harry Sloan, Jeff Sagansky and Eli Baker, Announces Completion of $300 million IPO GlobeNewswire January 20, 2026 Infinite Eagle Features a Warrantless Structure Each Unit Includes One Class A Ordinary Share and One Eagle Share Right to Receive 1/25th of a Class A Ordinary Share NEW

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA – ADCT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA – ADCT GlobeNewswire January 20, 2026 NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA (“ADC Therapeutics” or the “Company”) (NYSE: ADCT). Such investors are advised to contact

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. – LENZ

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. – LENZ GlobeNewswire January 20, 2026 NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of LENZ Therapeutics, Inc. (“LENZ” or the “Company”) (NASDAQ: LENZ). Such investors are advised to contact Danielle

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ramaco Resources, Inc. – METC

(NASDAQ:METC), NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Ramaco Resources, Inc. (“Ramaco” or the “Company”) (NASDAQ: METC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ramaco and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Air Products and Chemicals, Inc. – APD

(NYSE:APD), NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Air Products and Chemicals, Inc. (“Air Products” or the “Company”) (NYSE: APD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Air Products and certain of its

Scroll to Top